Artificial Intelligence and Uterine Fibroids: A Useful Combination for Diagnosis and Treatment
- PMID: 40429449
- PMCID: PMC12112542
- DOI: 10.3390/jcm14103454
Artificial Intelligence and Uterine Fibroids: A Useful Combination for Diagnosis and Treatment
Abstract
This manuscript examines the role of artificial intelligence (AI) in the diagnosis and treatment of uterine fibroids and uterine sarcomas, offering a comprehensive assessment of AI-supported diagnostic and therapeutic techniques. Through the use of radiomics, machine learning, and deep neural network models, AI shows promise in identifying benign and malignant uterine lesions, directing therapeutic decisions, and improving diagnostic accuracy. It also demonstrates significant capabilities in the timely detection of fibroids. Additionally, AI improves surgical precision, real-time structure detection, and patient outcomes by transforming surgical techniques such as myomectomy, robot-assisted laparoscopic surgery, and High-Intensity Focused Ultrasound (HIFU) ablation. By helping to forecast treatment outcomes and monitor progress during procedures like uterine fibroid embolization, AI also offers a fresh and fascinating perspective for improving the clinical management of these conditions. This review critically assesses the current literature, identifies the advantages and limitations of various AI approaches, and provides future directions for research and clinical implementation.
Keywords: artificial intelligence; deep neural network; high-intensity focused ultrasound; machine learning; magnetic resonance imaging; myoma; uterine fibroids; uterine leiomyosarcoma.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures







Similar articles
-
The management of uterine fibroids in women with otherwise unexplained infertility.J Obstet Gynaecol Can. 2015 Mar;37(3):277-285. doi: 10.1016/S1701-2163(15)30318-2. J Obstet Gynaecol Can. 2015. PMID: 26001875
-
The Comparing Options for Management: PAtient-centered REsults for Uterine Fibroids (COMPARE-UF) registry: rationale and design.Am J Obstet Gynecol. 2018 Jul;219(1):95.e1-95.e10. doi: 10.1016/j.ajog.2018.05.004. Epub 2018 May 8. Am J Obstet Gynecol. 2018. PMID: 29750955 Free PMC article.
-
EMAS position statement: management of uterine fibroids.Maturitas. 2014 Sep;79(1):106-16. doi: 10.1016/j.maturitas.2014.06.002. Epub 2014 Jun 9. Maturitas. 2014. PMID: 24975954
-
Management of Uterine Fibroids and Sarcomas: The Palermo Position Paper.Gynecol Obstet Invest. 2024;89(2):73-86. doi: 10.1159/000537730. Epub 2024 Feb 21. Gynecol Obstet Invest. 2024. PMID: 38382486 Review.
-
Progress in High Intensity Focused Ultrasound Ablation for Fertility Preservation Therapy of Uterine Fibroids and Adenomyosis.Reprod Sci. 2025 Jan;32(1):15-25. doi: 10.1007/s43032-024-01745-y. Epub 2024 Nov 12. Reprod Sci. 2025. PMID: 39532767 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources